Advertisement
Advertisement
BRNS
Barinthus Biotherapeutics plc - ADR
0.66
USDSponsored
-0.01
-1.48%
Jun 24, 16:00 UTC -4
Closed
After-Market
0.67
+0.01
+2.11%
BRNS Earnings Reports
Positive Surprise Ratio
BRNS beat 14 of 21 last estimates.
67%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.28
Implied change from Q1 26 (Revenue/ EPS)
--
/+100.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/-46.15%
Barinthus Biotherapeutics plc - ADR earnings per share and revenue
On Apr 30, 2026, BRNS reported earnings of -0.14 USD per share (EPS) for Q1 26, beating the estimate of -0.28 USD, resulting in a 50.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.35% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an increase of 100.00% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
What were Barinthus Biotherapeutics plc - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Barinthus Biotherapeutics plc - ADR reported EPS of -$0.14, beating estimates by 50.98%, and revenue of --, 0% as expectations.
How did the market react to Barinthus Biotherapeutics plc - ADR's Q1 2026 earnings?
The stock price moved up 8.35%, changed from $0.60 before the earnings release to $0.65 the day after.
When is Barinthus Biotherapeutics plc - ADR expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Barinthus Biotherapeutics plc - ADR's next earnings report?
Based on 4
analysts, Barinthus Biotherapeutics plc - ADR is expected to report EPS of -$0.28 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement